Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Inducible expression of kallikrein in renal tubular cells protects mice against spontaneous lupus nephritis.

Shao X, Yang R, Yan M, Li Y, Du Y, Raman I, Zhang B, Wakeland EK, Igarashi P, Mohan C, Li QZ.

Arthritis Rheum. 2013 Mar;65(3):780-91. doi: 10.1002/art.37798. Erratum in: Arthritis Rheum. 2013 Apr;65(4):1106. Wakeland, Ward [corrected to Wakeland, Edward K].

2.

Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress.

Zhang JJ, Bledsoe G, Kato K, Chao L, Chao J.

Kidney Int. 2004 Aug;66(2):722-32.

3.

Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stress.

Li Y, Raman I, Du Y, Yan M, Min S, Yang J, Fang X, Li W, Lu J, Zhou XJ, Mohan C, Li QZ.

PLoS One. 2013 Jul 23;8(7):e67790. doi: 10.1371/journal.pone.0067790. Print 2013.

4.
5.

Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans.

Liu K, Li QZ, Delgado-Vega AM, Abelson AK, Sánchez E, Kelly JA, Li L, Liu Y, Zhou J, Yan M, Ye Q, Liu S, Xie C, Zhou XJ, Chung SA, Pons-Estel B, Witte T, de Ramón E, Bae SC, Barizzone N, Sebastiani GD, Merrill JT, Gregersen PK, Gilkeson GG, Kimberly RP, Vyse TJ, Kim I, D'Alfonso S, Martin J, Harley JB, Criswell LA; Profile Study Group; Italian Collaborative Group; German Collaborative Group; Spanish Collaborative Group; Argentinian Collaborative Group; SLEGEN Consortium, Wakeland EK, Alarcón-Riquelme ME, Mohan C.

J Clin Invest. 2009 Apr;119(4):911-23. doi: 10.1172/JCI36728.

6.

The lupus-susceptibility gene kallikrein downmodulates antibody-mediated glomerulonephritis.

Li QZ, Zhou J, Yang R, Yan M, Ye Q, Liu K, Liu S, Shao X, Li L, Zhou XJ, Wakeland EK, Mohan C.

Genes Immun. 2009 Jul;10(5):503-8. doi: 10.1038/gene.2009.7. Epub 2009 Mar 5.

7.

Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery.

Bledsoe G, Shen B, Yao Y, Zhang JJ, Chao L, Chao J.

Hum Gene Ther. 2006 May;17(5):545-55.

PMID:
16716111
8.

Renal Dnase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis.

Zykova SN, Tveita AA, Rekvig OP.

PLoS One. 2010 Aug 10;5(8). pii: e12096. doi: 10.1371/journal.pone.0012096.

9.

Kallikreins and lupus nephritis.

Ponticelli C, Meroni PL.

J Clin Invest. 2009 Apr;119(4):768-71.

10.

Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid.

Wu T, Ye Y, Min SY, Zhu J, Khobahy E, Zhou J, Yan M, Hemachandran S, Pathak S, Zhou XJ, Andreeff M, Mohan C.

Arthritis Rheumatol. 2014 Nov;66(11):3129-39. doi: 10.1002/art.38782.

11.

Micro-RNA analysis of renal biopsies in human lupus nephritis demonstrates up-regulated miR-422a driving reduction of kallikrein-related peptidase 4.

Krasoudaki E, Banos A, Stagakis E, Loupasakis K, Drakos E, Sinatkas V, Zampoulaki A, Papagianni A, Iliopoulos D, Boumpas DT, Bertsias GK.

Nephrol Dial Transplant. 2016 Oct;31(10):1676-86. doi: 10.1093/ndt/gfv374. Epub 2015 Nov 5.

PMID:
26546590
12.

NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis.

Oates JC, Mashmoushi AK, Shaftman SR, Gilkeson GS.

Lupus. 2013 Nov;22(13):1361-70. doi: 10.1177/0961203313507988. Epub 2013 Oct 8.

13.

Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis.

Pérez de Lema G, Maier H, Nieto E, Vielhauer V, Luckow B, Mampaso F, Schlöndorff D.

J Am Soc Nephrol. 2001 Jul;12(7):1369-82.

14.

Protective role for CCR5 in murine lupus nephritis.

Turner JE, Paust HJ, Bennstein SB, Bramke P, Krebs C, Steinmetz OM, Velden J, Haag F, Stahl RA, Panzer U.

Am J Physiol Renal Physiol. 2012 Jun 1;302(11):F1503-15. doi: 10.1152/ajprenal.00382.2011. Epub 2012 Mar 21.

15.

Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease.

Zoja C, Corna D, Benedetti G, Morigi M, Donadelli R, Guglielmotti A, Pinza M, Bertani T, Remuzzi G.

Kidney Int. 1998 Mar;53(3):726-34.

16.

Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.

Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A.

J Rheumatol. 2010 Jan;37(1):60-70. doi: 10.3899/jrheum.090194. Epub 2009 Dec 1.

PMID:
19955044
17.

Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.

Boswell JM, Yui MA, Endres S, Burt DW, Kelley VE.

J Immunol. 1988 Jul 1;141(1):118-24.

PMID:
3259964
18.

The role of aldosterone blockade in murine lupus nephritis.

Monrad SU, Killen PD, Anderson MR, Bradke A, Kaplan MJ.

Arthritis Res Ther. 2008;10(1):R5. doi: 10.1186/ar2353. Epub 2008 Jan 15.

19.

Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation.

Liu Y, Bledsoe G, Hagiwara M, Yang ZR, Shen B, Chao L, Chao J.

Am J Physiol Renal Physiol. 2010 Apr;298(4):F1033-40. doi: 10.1152/ajprenal.00518.2009. Epub 2010 Jan 20.

20.

Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain.

Xie C, Zhou XJ, Liu X, Mohan C.

Arthritis Rheum. 2003 Apr;48(4):1080-92.

Supplemental Content

Support Center